Skip to content

    Amphastar Pharmaceuticals (AMPH) stock price & financials

    View AMPH earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance27.8% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $191.21M
    $186.52M
    $170.53M
    $174.41M
    $191.84M
    +0.3%
    $183.10M
    -1.8%
    $171.17M
    +0.4%
    $183.90M
    +5.4%
    Stable
    Operating Profit
    $57.05M
    $45.14M
    $37.29M
    $42.18M
    $25.32M
    -55.6%
    $35.61M
    -21.1%
    $13.63M
    -63.5%
    $39.73M
    -5.8%
    Weakening
    Net Profit
    $40.43M
    $37.96M
    $25.29M
    $31.03M
    $17.35M
    -57.1%
    $24.43M
    -35.7%
    $6.42M
    -74.6%
    $30.35M
    -2.2%
    Weakening
    EPS
    $0.83
    $0.53
    $0.66
    $0.38
    -54.2%
    $0.14
    -73.6%
    $0.69
    +4.5%
    Weakening
    Other Income
    -$9.37M
    -$1.18M
    -$6.43M
    -$2.85M
    -$3.81M
    +59.3%
    -$3.69M
    -212.4%
    -$3.58M
    +44.4%
    -$1.19M
    +58.4%
    Weakening
    Interest
    $6.70M
    $6.42M
    $6.29M
    $6.28M
    $6.28M
    -6.2%
    $6.63M
    +3.2%
    $6.55M
    +4.2%
    $6.66M
    +6.0%
    Strengthening
    Depreciation
    Profit before Tax
    $47.68M
    $43.96M
    $30.86M
    $39.34M
    $21.51M
    -54.9%
    $31.91M
    -27.4%
    $10.05M
    -67.4%
    $38.54M
    -2.0%
    Weakening
    MarginsOPM
    29.8%
    24.2%
    21.9%
    24.2%
    13.2%
    -55.7%
    19.4%
    -19.6%
    8.0%
    -63.6%
    21.6%
    -10.7%
    Weakening
    Tax
    15.2%
    13.6%
    18.1%
    21.1%
    19.4%
    +27.2%
    23.4%
    +71.9%
    36.1%
    +99.9%
    21.3%
    +0.7%
    Strengthening
    ReturnsROIC
    5.7%
    5.4%
    3.6%
    4.4%
    2.5%
    -57.1%
    3.5%
    -35.7%
    0.9%
    -74.6%
    4.3%
    -2.2%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$86.34M$73.69M$92.64M$126.35M$156.10M$144.30M$151.61M$170.18M$223.61M
    Short-Term Investments
    Total Current Assets$220.34M$255.24M$279.68M$318.12M$378.32M$489.60M$534.07M$636.02M$630.95M
    Net PP&E$210.42M$252.66M$280.10M$271.14M$263.82M$315.08M$344.24M$353.50M$388.97M
    Goodwill$3.95M$3.63M$3.94M$3.31M$3.13M$3.22M$3.05M$3.40M$3.31M
    Intangibles$9.09M$8.29M$7.45M$6.33M$4.95M$580.85M$558.39M$533.34M$615.30M
    Total Assets$513.56M$586.97M$631.24M$671.53M$741.99M$1.51B$1.58B$1.63B$1.74B
    LiabilitiesTotal Current Liabilities$106.83M$90.01M$112.20M$103.81M$94.86M$225.41M$173.76M$158.16M$263.20M
    Short-Term Debt
    Long-Term Debt$49.10M$46.32M$45.92M$78.19M$76.64M$603.17M$613.53M$619.71M
    Long-Term Leases$16.32M$17.46M$24.70M$23.69M$29.72M$41.88M$37.68M$67.47M
    Total Liabilities$149.20M$159.44M$182.51M$226.01M$213.33M$873.49M$845.17M$840.49M$975.61M
    EquityCommon Stock & APIC$5.0K$5.0K$5.0K$6.0K$6.0K$6.0K$6.0K$6.0K$6.0K
    Retained Earnings$67.48M$116.37M$117.77M$180.34M$271.72M$409.27M$568.79M$666.88M$703.65M
    Total Equity$332.44M$381.37M$402.31M$445.52M$528.66M$639.42M$732.30M$788.80M$768.16M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating$38.19M$41.76M$57.27M$97.99M$89.18M$183.50M$213.39M$156.12M$184.61M
    Cash from Investing-$42.18M-$50.53M-$36.41M-$28.67M-$32.78M-$649.12M-$124.93M-$70.33M-$52.05M
    Cash from Financing$25.01M-$3.78M-$2.25M-$37.02M-$26.44M$454.09M-$80.95M-$67.42M-$96.46M
    SummaryCapital Expenditure-$46.81M-$41.55M-$33.85M-$27.46M-$24.03M-$38.17M-$41.04M-$34.88M-$31.72M
    Free Cash Flow-$8.62M$207.0K$23.41M$70.54M$65.15M$145.34M$172.34M$121.23M$152.89M
    FCF Margin-2.9%0.1%6.7%16.1%13.1%22.6%23.5%16.8%20.9%

    Ratios